List of publications on a keyword: «new psychoactive substances»


Медицина

Publication date: 16.02.2017
Evaluate the material Average score: 3 (Всего: 3)
Mrykhin Vladimir Valerievich , candidate of medical sciences , доцент
FSFEI of HE “Rostov State Medical University” of Russian Ministry of Health , Ростовская обл
Antsyborov Andrey Viktorovich , degree-seeking student , psychiatrist, addiction psychiatrist, assistant
Medical center "Alpha Health" , Ростовская обл

«Psychiatric aspects of designer drugs and new psychoactive substances consumption»

Download an article

According to the authors, appeared not long ago new psychoactive substances (designer drugs), including synthetic cannabinoids, derivatives of cathinone, phenethylamines, new stimulants, synthetic opioids, tryptamine derivatives, phencyclidine, piperazine, agonists of GABA (A/B) receptors have become a serious problem for both consumers and doctors. Consumers of these substances are attracted primarily by the intensity of psychoactive effects, as well as «legal purity», which is declared by shadow producers. This indicates that there are some significant difficulties of laboratory typing of new surfactants. Designer drugs when ingested, can affect a range of neurotransmitter pathways/receptors: dopamine, cannabinoid (CB1), GABA(A/B), 5-HT2A, glutamate, and k-opioid receptors (KOR), the imbalance of which leads to the development of polymorphic psychotic disorders.

Publication date: 28.07.2017
Evaluate the material Average score: 4 (Всего: 3)
Antsyborov Andrey Viktorovich , degree-seeking student , psychiatrist, addiction psychiatrist, assistant
Medical center "Alpha Health" , Ростовская обл
Asadulin Azat Railevich , candidate of medical sciences , доцент
FSBEI HE "Bashkir State Medical University" of the Ministry of Healthcare of the Russian Federation , Башкортостан Респ

«Psychoactive effects and toxic reactions associated with the use of mephedrone and methylone (review)»

Download an article

One of the most common classes among new psychoactive substances are substituted cathinones. The most popular substances among consumers, representatives of this class, are mephedrone and methylone. In this review, the accumulated scientific data on clinical effects, side effects, mechanisms of action associated with the use of methylone and mephedrone are systematized. When writing the review, two representative databases were used to find the scientific sources of PubMed and Google Scholar. The authors also used data from the site Erowid Center (non-profit educational organization in the United States, which provides information on psychoactive plants and chemicals). The literature search was conducted between 2005 and 2015.

Medicine

Publication date: 14.06.2019
Evaluate the material Average score: 0 (Всего: 0)
Antsyborov Andrey Viktorovich , degree-seeking student , psychiatrist, addiction psychiatrist, assistant
Medical center "Alpha Health" , Ростовская обл
Dubatova Irina Vladimirovna , candidate of medical sciences , associate professor
FSFEI of HE “Rostov State Medical University” of Russian Ministry of Health , Ростовская обл

«New psychoactive substances: psychiatrist's view»

Download an article

Appearing not long ago, new psychoactive substances (designer drugs), including synthetic cannabinoids, derivatives of cathinone, phenethylamines, new stimulants, synthetic opioids, tryptamine derivatives, phencyclidine, piperazine, the GABA (A/B) receptors agonists, have become a serious problem for consumers and for physicians. Consumers of these substances are attracted primarily by the intensity of psychoactive effects, and the «legal high» declared by the black manufacturers, which indicates that significant difficulties in a laboratory identification of new surfactants. Designer drugs, when ingested, can be influenced on many neurotransmitter pathways/receptors: dopamine, cannabinoid (CB1), GABA (A/B), 5-HT2A, glutamate, and k-opioid receptors (KOR), the imbalance of which leads to the development of polymorphic psychotic disorders.